UCAL LIMITED has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

UCAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-9.4%Reaction day

₹165.27

prior close

₹154.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%-9.5% vs market

Auto Components & Equipments peers, median of 106sector+0.0%-9.4% vs sector

On the reaction day the stock moved 9.5 pts less than Nifty Microcap 250 and 9.4 pts less than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.6

10m

-1.3

15m

-1.9

30m

-0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-9.4+0.1-9.5+0.0-9.4

Next day

-9.5-0.2-9.4-0.3-9.3

-11.7+0.3-12.0+0.0-11.7

-11.1+0.9-11.9+1.0-12.0

-9.6+0.8-10.4+1.3-11.0

-7.9+2.2-10.1+1.9-9.8

-5.9+3.4-9.3+3.3-9.2

15d

-6.9-0.8-6.1-0.7-6.2

-3.7+2.9-6.7+3.4-7.1

-12.7+0.8-13.6+0.7-13.5

-17.9+0.0-17.9+1.3-19.2

UpDownMarket · Nifty Microcap 250Sector · Auto Components & Equipments peers, median of 106Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

UCAL LIMITED has filed its financial results with the NSE for the fiscal year/quarter ended March 31, 2025. No specific revenue, profit, or margin figures are disclosed in the headline itself. This is a routine regulatory filing notifying the exchange that the company's audited or unaudited results have been submitted. Investors would need to review the detailed results document for actual performance numbers.

Likely market impact

Neutral on its face — this is a standard compliance filing. Shareholders should look at the actual results (revenue, PAT, margins) within the submitted document to assess the company's financial health and any stock price implications.